KOSDAQ - Delayed Quote KRW

ChoA Pharmaceutical Co., LTD. (034940.KQ)

1,617.00 -6.00 (-0.37%)
At close: 3:30 PM GMT+9
Loading Chart for 034940.KQ
DELL
  • Previous Close 1,623.00
  • Open 1,623.00
  • Bid --
  • Ask --
  • Day's Range 1,609.00 - 1,631.00
  • 52 Week Range 1,570.00 - 2,410.00
  • Volume 25,066
  • Avg. Volume 79,749
  • Market Cap (intraday) 50.094B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets. It also provides medicine supply and pharmacy management services. The company exports its products to approximately 20 countries worldwide. The company was founded in 1964 and is headquartered in Seoul, South Korea.

www.choa.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Related News

Performance Overview: 034940.KQ

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

034940.KQ
18.37%
KOSPI Composite Index
1.21%

1-Year Return

034940.KQ
26.00%
KOSPI Composite Index
3.09%

3-Year Return

034940.KQ
63.46%
KOSPI Composite Index
17.54%

5-Year Return

034940.KQ
65.45%
KOSPI Composite Index
18.13%

Compare To: 034940.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 034940.KQ

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.70%

  • Return on Assets (ttm)

    -6.88%

  • Return on Equity (ttm)

    -24.69%

  • Revenue (ttm)

    62.97B

  • Net Income Avi to Common (ttm)

    -10.51B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.36B

  • Total Debt/Equity (mrq)

    45.15%

  • Levered Free Cash Flow (ttm)

    -850.27M

Company Insights: 034940.KQ

People Also Watch